Vimarsana
Biggest News Aggregation in the World

Mark Aronica News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Aronica. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Aronica Today - Breaking & Trending Today

A Decongestant in Cold Medicines Is Ineffective. Here's What to Use Instead. - Vimarsana News

A Decongestant in Cold Medicines Is Ineffective. Here's What to Use Instead.

Here’s what you can use instead.

If decongestant in many cold medicines is ineffective, what should sniffly consumers do? - Vimarsana News

If decongestant in many cold medicines is ineffective, what should sniffly consumers do?

Here's what you can use instead.

SLIT Safe for Asthma, but Efficacy Data Are Lacking - Vimarsana News

SLIT Safe for Asthma, but Efficacy Data Are Lacking

Sublingual immunotherapy appears safe for allergy, but new research suggests that although it's safe for patients with asthma, there's insufficient evidence on its efficacy in asthma management.

Cleveland Clinic joins multicenter clinical trial of allergic reactions to mRNA COVID-19 vaccine - Vimarsana News

Cleveland Clinic joins multicenter clinical trial of allergic reactions to mRNA COVID-19 vaccine

The main campus of Cleveland Clinic Cleveland Clinic will serve as the only clinical site in Ohio to participate in a national multi-center clinical trial to study severe allergic reaction to mRNA COVD-19 vaccines, according to a news release. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is leading the trial to study the incidents of such anaphylactic reactions and whether certain risk factors increase the likelihood of experiencing the potentially life-threatening allergic reactions. Current research suggest anaphylaxis ...

Cleveland Clinic joins clinical trial of allergic reactions to COVID-19 vaccine - Vimarsana News

Cleveland Clinic joins clinical trial of allergic reactions to COVID-19 vaccine

Cleveland Clinic joins clinical trial of allergic reactions to COVID-19 vaccine The main campus of Cleveland Clinic Cleveland Clinic will serve as the only clinical site in Ohio to participate in a national multi-center clinical trial to study severe allergic reaction to mRNA COVD-19 vaccines, according to a news release. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is leading the trial to study the incidents of such anaphylactic reactions and whether certain risk factors increase the likelihood of experiencing the potenti...